BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Novadip Biosciences S.A.

Headquarters: Mont-Saint-Guibert, Belgium
Year Founded: 2013
Status: Private

BioCentury | May 1, 2025
Management Tracks

Augustine follows up venture round with pair of C-suite hires

Plus: Management changes at Cidara, Fujifilm Cellular Dynamics and Transneural
BioCentury | Apr 2, 2025
Management Tracks

FDA names Scott Steele acting head of CBER after Marks’ ouster 

Plus: New managing directors at Vida and updates from Nxera, Korro and Novadip
BioCentury | Sep 13, 2024
Data Byte

PanTera largest Belgian A round to date

Only nine other biotechs have raised over $25 million since 2015
BioCentury | Jan 4, 2023
Management Tracks

Ex-Checkmate CEO Bash to lead ZielBio

Plus: Allogene’s Amado joins Zai Lab, and updates from bluebird bio, Rejuvenate, Novadip and more
BioCentury | Nov 4, 2022
Deals

Nov. 4 Quick Takes: Bayer returns rights to Ionis’ antithrombotic

Plus Vicore gains on IPF data and updates from Acrivon, BioAtla, Novadip and more
BioCentury | Oct 29, 2021
Product Development

Oct. 28 Quick Takes: Rafael shares sink on oncology readouts

Phathom, HealthCare Royalty pull offerings, plus Merck, Sanofi raise guidance after strong quarters and more  
BioCentury | Apr 7, 2017
Finance

Fast-growing evergreen

How returns from Ogeda’s exit could affect Fund+’s investment strategy
BioCentury | Oct 26, 2016
Financial News

Fund+ closes EUR 125M fund

BioCentury | Sep 14, 2015
Financial News

Novadip completes venture financing

Items per page:
1 - 10 of 11
Help Center
Username
Request Training
Submit Data Correction
Ask a Question